CD274 and neoplasm: Additionally, ERBB2 may modulate the tumor microenvironment by upregulating programmed death-ligand 1 (PD-L1), potentially contributing to immune evasion, which could explain its association with aggressive disease phenotypes in familial breast cancer and specific clinical factors such as hormonal status and chronic conditions.